KAELEIGH LOWDEN: Open Payments
NPI 1902567019 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 59 payments from 12 companies in 2025. Trend: 2023 $256 · 2024 $1,535 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $240 |
| Novartis Pharmaceuticals Corporation | 15 | $213 |
| AstraZeneca Pharmaceuticals LP | 5 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $108 |
| Paratek Pharmaceuticals, Inc. | 6 | $106 |
| ABBVIE INC. | 5 | $97 |
| Lilly USA, LLC | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| KYOWA KIRIN, INC. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: LEQVIO, Wegovy, Kerendia, Ozempic, FARXIGA, NUZYRA, MOUNJARO, QULIPTA.
Industry payments across WV — which companies pay providers there.
